Results 91 to 100 of about 119,526 (169)

A new light on an old disease: adhesion signaling in pemphigus vulgaris. [PDF]

open access: yes, 2014
Disruption of desmosomal cadherin adhesion leads to the activation of intracellular signaling pathways that are responsible for blister formation in pemphigus vulgaris (PV).
Müller, Eliane Jasmine   +5 more
core   +1 more source

Novel Serum Oxidative Stress Biomarkers in Pemphigus Vulgaris: Clinical Insights and Implications for Pathogenesis

open access: yesDermatology Practical & Conceptual
Introduction: Pemphigus vulgaris is an autoimmune disorder characterized by blistering of the skin and mucous membranes due to the loss of cohesion between keratinocytes.
Naglaa El Sayed   +3 more
doaj   +1 more source

Pemphigus Foliaceus and Pemphigus Erythematosus are the Most Common Subtypes of Pemphigus in Northern Finland

open access: yesActa Dermato-Venereologica, 2019
Pemphigus is an autoimmune skin disease characterized by blistering and erosions of the skin and mucous membranes. Pemphigus is rare in Northern and Western Europe but its incidence is higher around the Mediterranean Sea.
Anna-Kaisa Försti   +5 more
doaj   +1 more source

Pulmonary embolism in pemphigus vulgaris, the need for judicious immunotherapy [PDF]

open access: yes, 2005
Pemphigus vulgaris is a serious chronic mucocutaneous ailment. In recent decades advances in diagnostic and therapeutic measures have led to a significant decline in morbidity and mortality.
Ashraf, Omer, Sharif, Hasanat
core  

Comparative evaluation of salivary IL-1α, IL-10 and TNF-α concentrations in patients with oral pemphigus vulgaris lesions by ELISA technique

open access: yesمجله دانشکده دندانپزشکی اصفهان, 2011
Introduction: Based on recent research, cytokines particularly IL-1α, IL-10, and INF-α might play a role in the pathogenesis of pemphigus vulgaris. Some autoimmune diseases have been successfully treated with the use of antibodies against cytokines.
Faezeh Khozeimeh, Majid Jafari
doaj  

Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?

open access: yesAntibodies
Rituximab is currently approved for patients affected by moderate-to-severe pemphigus vulgaris, a severe autoimmune blistering skin disease that can be life-threatening.
Christian Ciolfi   +2 more
doaj   +1 more source

Complement in pemphigus vulgaris and other bullous dermatoses

open access: yes, 1975
The behaviour of the complement and of its components C4 and C3 has been studied in serum and in blister fluid both in patients with pemphigus vulgaris and other bullous dermatoses and in healthy subjects with experimentally induced blisters. The results
VOLPI, L.   +3 more
core   +1 more source

Oral pemphigus vulgaris

open access: yes, 2017
Pemphigus is a group of potentially life-threatening autoimmune mucocutaneous diseases characterized by epithelial blistering affecting cutaneous and/ or mucosal surfaces. Pemphigus affects 0.1-0.5 patients per 100,000 population per year.
Mohit Sharma
core   +1 more source

Vascular cognitive impairment in Pemphigus vulgaris: a case report

open access: yesDementia & Neuropsychologia
Pemphigus vulgaris is a systemic auto-immune medical condition that mainly manifests with changes in skin and vasculopathy. This is a case report of a 69-year-old male with confirmed histopathologic diagnosis of Pemphigus vulgaris presenting ulterior ...
José Ibiapina Siqueira- Neto   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy